First-of-its-Kind TechnologyRemove Sagging Skin Without Surgery

ellacor with Micro-Coring Technology is the first and only non-surgical solution to remove sagging skin without surgery.

How the ellacor Micro-Coring® Procedure Works

ellacor 2.0 now available

Download the ellacor 2.0 brochure

Visible Results Without Surgery.

Don’t take our word for it. See the results from patients who have experienced the ellacor difference.

3 Months After 1 ellacor Procedure
Photos courtesy of Henry A. Mentz, MD

6 Months After 2 ellacor Procedures
Photos courtesy of Omar A. Ibrahimi, MD, PhD

2 Months After 2 ellacor Procedures
Photos courtesy of David Weir, NP

1 Month After 1 ellacor Procedure
Photos courtesy of Mathew M. Avram, MD, JD

3 Months After 1 ellacor Procedure
Photos courtesy of Jill Waibel, MD

3 Months After 1 ellacor Procedure
Photos courtesy of Siamak Agha, MD, PhD

See More Results

The Technology You Have Been Looking For.

As patients’ expectations continue to rise, you need a novel solution that can deliver better results. Developed alongside physicians, ellacor provides value to you and your practice while delivering the results your patients expect, treating moderate to severe wrinkles in the mid to lower face without surgery.

About The Product

Ellacor procedure showing needles making micro-cores of skin.

Proprietary excision mechanism removes full thickness micro-cores of dermal and epidermal tissue.

Ellacor procedure illustration showing micro-cores in skin.

With no heat used or produced during treatment, ellacor does not cause thermal injury.

Ellacor procedure illustration showing tightening skin.

The skin naturally realigns along the relaxed skin tension lines, resulting in improved skin architecture.²

Pivotal Clinical Study Results.

The ellacor System with Micro-Coring Technology was evaluated in more than 200 patients.

First and only FDA-cleared procedure to non-surgically remove excess skin

of patients showed improvement in moderate to severe wrinkles³

overall patient satisfaction when considering all treatment sides³

“ellacor takes advantage of the scientific concept of Micro-Coring which removes extremely tiny columns of tissue that heal without any visible scarring.”

Omar A. Ibrahimi, M.D., Ph.D.
Board-Certified Dermatologist
Connecticut Skin Institute

“Prior to ellacor, there wasn’t a way of excising skin without leaving a visible scar… This breakthrough technology removes sagging skin on the microscale and provides trained clinicians with a unique solution for their patients.”

Ashish C. Bhatia, M.D., F.A.A.D.
Board-Certified Dermatologist
Oak Dermatology, IL
Cytrellis Medical Director

“In my opinion, this new technology works very well for the beginning of skin laxity at the jowls, around the mouth and lower face. I am VERY enthusiastic about Micro-Coring with ellacor!”

Elizabeth Tanzi, M.D.
Board Certified-Dermatologist
Captial Laser & Skin Care

“In middle-aged patients, we’re going to use it to stave off a facelift. For women who have had a facelift and don’t want a second one, we’re going to be able to use it on them as well.”

Jill Waibel, M.D.
Board-Certified Dermatologist
Miami Dermatology and Laser Institute

“Because this is a mechanical device and not thermal like lasers or radiofrequency, it allows for rapid healing without scarring. And unlike microneedling, where skin is temporarily displaced, ellacor actually removes skin on the micro-scale and is the first device to do so.”

Roy G. Geronemus, M.D.
Board-Certified Dermatologist
Laser & Skin Surgery Center of New York

“Patients want something with a surgical result, without having to go through the surgery. Ellacor is really the first technology to do this.”

Paul Frank, M.D.
Board Certified-Dermatologist
PFRANKMD

“Deep layer facelifts do a good job with soft tissue repositioning in the midface. However, none of these surgeries do much for lines around the mouth in that area – that’s sort of the sweet spot for ellacor and I think my best results for perioral aging have come with a combination of ellacor…”

Henry A. Mentz, M.D.
Board-Certified Plastic Surgeon
The Aesthetic Center for Plastic Surgery

“Ideally a patient perhaps in her forties to sixties… just beginning to develop some jowls, marionette lines, some perioral lines, some of those fine lines in the lower cheeks. But they’re either not ready for surgery yet or they’re just unwilling to undergo surgery – that I see as the perfect candidate.”

John Taylor, M.D.
Board-Certified Plastic Surgeon
Allure Plastic Surgery Center

“So I think that, in terms of the skin, because it [ellacor] can remove it… I think that’s the final tool in the toolbox. There’s going to come a time in the not so distant future where it will be very rare for me to go into the OR for cosmetics.”

Oren Tessler, M.D.
Board-Certified Plastic Surgeon
Tessler Plastic Surgery

“The fact that you can actually offer patients a modality to have their skin removed by 7 or 8% from the treatment area without creating a scar… it creates substantial improvement.”

Siamak Agha, M.D., PhD, FACS
Board-Certified Plastic Surgeon
The Aesthetic Centers

“ellacor is not like micro-needling, what you’re doing is taking small micro cores of skin…when you get the removal of that skin – it’s actually very smart – then the skin contracts.”

Rod Rohrich, M.D.
Board-Certified Plastic Surgeon
Dallas Plastic Surgery Institute

“There’s nothing like it on the market. It’s a solid, effective product and a disruptive technology. Unlike an RF-based or ultrasound treatment, we actually remove skin, which is unlike microneedling. Its Micro-Coring treatment fits somewhere between energy-based skin rejuvenation and actual face-lift surgery.”

Steven Cohen, M.D.
Board-Certified Plastic Surgeon
Faces Plus

Interested in Becoming an ellacor Provider?

Get the full story on how ellacor can help elevate your practice.

Become A Provider

INDICATION FOR USE

The ellacor® System with Micro-Coring® technology is indicated for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.

Important Safety Information

RISKS & BENEFITS

Your medical professional will discuss the following side effects with you prior to treatment. Proper pre- and post-treatment care reduces the risk of these side effects; however, some conditions may or may not resolve over time. Side effects associated with this procedure may include: redness, swelling, bruising, burning, dryness, roughness, tightness/pulling of skin, crusting, pain/discomfort, tenderness, tingling, bleeding, numbness, skin peeling, or circular marks on skin.

Other side effects not commonly observed with this procedure may include: itching, hyper/hypo pigmentation, hematoma, infection, scarring, skin irregularities, skin necrosis, uneven appearance of the treated regions (left and right sides of face), or anesthesia toxicity (anesthesia-related complications may include allergic reaction and possibly death).

CONTRAINDICATIONS

The ellacor® procedure should not be used for the treatment of areas of skin with dermatosis (e.g. skin tumors, keloids or in case of predisposition to keloids, solar keratosis, warts, or birthmarks), area within the bony orbital rim; mucous membranes; areas where silicone or synthetic material is implanted.
The ellacor® procedure should not be used on patients that are pregnant or nursing mothers, suffering from open wounds, sores, or irritated skin in the treatment area, have an allergy to stainless steel or allergy to topical, oral, or injected medications or preparations that may be used during the procedure, such as petrolatum, lidocaine, bupivacaine, chlorhexidine, or povidone-iodine. Patients that have a history or presence of any clinically significant bleeding disorder, have dermatological or autoimmune conditions that may affect the treatment outcome; these may include, but are not limited to: actinic keratosis, raised nevi, rosacea, melasma, active acne, cutaneous papules/nodules, active inflammatory lesions, dermatitis, psoriasis, cellulitis, urticarial folliculitis, acute inflammatory phase of scleroderma, rheumatoid arthritis, eczema, psoriasis, allergic dermatitis, collagen disorders, or lupus should not be treated with the ellacor® procedure. Additionally, patients that have systemic infections or acute local skin infections such as Hepatitis disorders type A, B, C, D, E or F or HIV infection, take a high dose of anti-coagulants or blood-thinning substances (e.g. aspirin, nonsteroidal anti-inflammatory drugs, NSAIDs, warfarin, heparin, acetylsalicylic acid during the previous fourteen (14) days), are on courses of chemotherapy, high-dose corticosteroid use, or radiation in the treatment area, have undergone plastic surgery of the face within the last twelve (12) months or have any facial surgical scars less than twelve (12) months old, have undergone injections of dermal fillers, fat, or botulinum toxin, as well as any minimally invasive/invasive skin treatment in the treatment area during the previous six (6) months, or have scars less than six (6) months old in the treatment area should not be treated with the ellacor® procedure.

TREATMENT PRECAUTIONS

Appropriateness for treatment is based on the clinical assessment of the patient by the treating physician. Use caution when treating patients with the following conditions or taking the following medications:

History of hyperpigmentation
Recent exposure to sun or tanning beds with red, peeling, or swollen skin
Active, chronic, or recurrent infection including bacterial or fungal infections
History of active herpes simplex infection in the treatment area
Use of topical or oral preparations/medications that may change the skin integrity or prolong healing
Over the Counter (OTC) and herbal supplements that may increase the risk of bleeding or prolong healing, such as gingko biloba, garlic, ginseng, dong quai, fever few, and fish oil
Other medications or medical conditions that may interfere with the treatment or that the treatment provider believes may compromise the safety of the patient or the efficacy of the treatments. Refer the patient to their Primary Care Physician (PCP) or other managing health care provider or clearance prior to treatment
Recent trauma or surgery to the treatment area

Data based on 36 providers and 17 patients that have completed all ellacor 2.0 experience feedback surveys as of November 2024.
Cytrellis studies using OCT (Optical Coherence Tomography) have demonstrated absence of holes, approximately 10 minutes post procedure (2017)
Pivotal Study to Evaluate the Effectiveness of a Micro-Coring Device Treating Moderate to Severe Facial Wrinkles. ClinicalTrials.gov NCT 03573271; submitted for publication. 51 subjects completed the pivotal study; subjects were treated 2-3 times with 7%-8% skin removal and up to 5mm needle coring depth. Each patient heals differently; mild to moderate side effects may still be present up to 30 days post-treatment per physician assessment. All clinical data, including patient healing, treatment pain on the 0-10 Wong-Baker Scale, Global Aesthetic Improvement Scale scores, and Subject Satisfaction is on file with Cytrellis.